Filling the need for trusted information on national health issues…

Vaccines

  • Your Selections:

Refine Results

date

Tags

Blocking Transmission Key In Malaria Fight

Devex: Block transmission Martin Edlund, CEO of Malaria No More “…[F]or malaria, the transit between mosquito and man isn’t just a joyride — it’s an essential step in reproduction. By blocking transmission, you isolate the mosquito and interrupt that process. … The classic approach to blocking transmission is to protect…

Research Continues To Develop Safe, Effective Ebola Vaccine

Media sources report on efforts to develop a vaccine to treat or prevent Ebola. CIDRAP News: At symposium, vaccine seen as best hope for arresting Ebola “At a wide-ranging symposium on West Africa’s Ebola epidemic [Tuesday], much of the attention focused on the hope of an effective vaccine, as a…

Investigational Rotavirus Vaccine In Late-Stage Clinical Trials

Reuters: Sanofi’s Rotavirus vaccine enters late-stage trials “French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India. The vaccine is aimed at rotavirus infections which cause gastroenteritis…” (Callus, 10/14).

Canadian Ebola Vaccine Begins Human Trials

News outlets report on the start of clinical trials testing a Canadian Ebola vaccine. Agence France-Presse: Experimental Canadian Ebola vaccine starts human tests (10/13). Globe and Mail: As vaccine trials begin, Canada set to review Ebola strategy (Wingrove, 10/14). Reuters: Human testing begins on NewLink Genetics’ Ebola vaccine (Grover, 10/13).…

U.S. Officials Comment On Dallas Ebola Cases, Research Into Vaccines

News outlets report on U.S. health officials’ statements about the U.S. Ebola cases and research for a vaccine. Agence France-Presse: First U.S. Ebola infection result of ‘protocol breach’ “A Texas health care worker has become the first person to contract Ebola on American soil, authorities confirmed, blaming a safety breach…

First African Ebola Vaccine Trial Begins In Mali

News outlets report on the beginning of the first African Ebola vaccine trial. The Hill: Ebola vaccine trial begins in Africa “The first Ebola vaccine trial in Africa has started under the supervision of the University of Maryland, according to a report. Three health care workers in Mali received the…

Ebola Raises Questions On Incentives For Drug, Vaccine Research

TIME: Ebola Should Change How We Fund Drugs for Emerging Disease “Emerging and infectious diseases are having a moment for all the worst reasons, with credit due to the Ebola outbreak. But scientists studying other emerging diseases beyond Ebola are hopeful that the attention on the disease — and what…

Testing Of Experimental Ebola Vaccine Raises Ethical, Logistical Questions

News outlets discuss the ethical and logistical challenges surrounding the testing of an Ebola vaccine. Bloomberg News: Ebola Vaccine Trials May Give Placebo to Those at Risk “As global health officials rush to begin human trials of two promising Ebola vaccines in West African medical workers, a daunting question remains unanswered:…

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.